The use of #realworldevidence is expanding to design, test and review #raredisease treatments, but market access challenges persist as payers in the U.S. and Europe continue to express doubts. Our recent survey sheds light on the perception gap. https://www.syneoshealth.com/insights-hub/real-world-value-advancing-payer-understanding-rwe-rare-disease …pic.twitter.com/RtX3Zay38k
18:29 - 28. sij 2020.
0 replies
1 proslijeđeni tweet
0 korisnika označava da im se sviđa
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.